Although these mutations are characteristic of adenocarcinoma tumors [8, 9], it has been recently shown that some squamous cell carcinoma patients respond to anti-EGFR therapy [10] and that high EGFR expression levels correlate with better responses in these patients [11], highlighting the therapeutic relevance of EGFR in this setting. Here, EGFR is linked to squamous cell carcinoma.